Tirzepatide
$335.00
Dual GIP/GLP-1 Receptor Agonist | Metabolic Research Peptide | For Laboratory Use Only
Overview Tirzepatide is a next-generation dual incretin agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Researchers study this molecule for its powerful role in metabolic regulation, appetite signaling, glucose control, and body-composition pathways.
Because of its dual-pathway mechanism, Tirzepatide is frequently selected for research exploring advanced strategies for metabolic optimization and multi-hormonal modulation.
Description
Key Research Points
Dual Incretin System Activation
Tirzepatide uniquely stimulates:
-
GIP receptors – linked to insulin sensitivity & metabolic flexibility
-
GLP-1 receptors – linked to appetite regulation & glucose control
This dual agonism is of significant interest due to its amplified metabolic effects.
Metabolic & Endocrine Research
Researchers investigate Tirzepatide for potential roles in:
-
Regulation of body weight & adiposity
-
Appetite-signaling pathways
-
Improved insulin response & glycemic markers
-
Enhanced metabolic efficiency and energy balance
Body Composition Pathways
Scientific interest includes:
-
Fat-loss models
-
Changes in visceral fat mass
-
Glucose and lipid metabolism
-
Endocrine system modulation
Related products
-
Retatrutide
Price range: $185.00 through $225.00Select options This product has multiple variants. The options may be chosen on the product page -
-
Reviews
There are no reviews yet.